Co-Author: Emma C. Bowers, MS Why should toxicologists and risk assessors care about epigenetics? According to Dana C. Dolinoy, PhD, University of Michigan School of Public Health, “many toxicologists may already be studying epigenetic phenomena — they just might not realize it.” The...
Attrition of novel drug candidates due to cardiovascular liabilities (including proarrhythmic risk due to delayed ventricular repolarization and Torsades-de-Pointes arrhythmia) remains a hurdle for drug discovery efforts, a hurdle which may be mitigated by the use of human induced pluripotent...
11190 Sunrise Valley Dr., Suite 300,Reston, VA 20191 703.438.3115 sothq@toxicology.org
Join SOTJoin a Component GroupManage Your ProfileVolunteer
Privacy PolicyCode of ConductCode of Ethics